Managing antiphospholipid syndrome in children and adolescents: current and future prospects (2022)
Islabao, Aline Garcia; Trindade, Vitor Cavalcanti; Mota, Licia Maria Henrique da; Andrade, Danieli Castro Oliveira; Silva, Clovis Artur Almeida da 
Source: Pediatric drugs. Unidade: FM
Subjects: CRIANÇAS, ADOLESCENTES, TROMBOSE, SINAIS E SINTOMAS, FOSFOLIPÍDEOS, COMPLICAÇÕES NA GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ISLABAO, Aline Garcia et al. Managing antiphospholipid syndrome in children and adolescents: current and future prospects. Pediatric drugs, v. 24, n. 1, p. 13-27, 2022Tradução . . Disponível em: https://doi.org/10.1007/s40272-021-00484-w. Acesso em: 05 nov. 2024.APA
Islabao, A. G., Trindade, V. C., Mota, L. M. H. da, Andrade, D. C. O., & Silva, C. A. A. da. (2022). Managing antiphospholipid syndrome in children and adolescents: current and future prospects. Pediatric drugs, 24( 1), 13-27. doi:10.1007/s40272-021-00484-wNLM
Islabao AG, Trindade VC, Mota LMH da, Andrade DCO, Silva CAA da. Managing antiphospholipid syndrome in children and adolescents: current and future prospects [Internet]. Pediatric drugs. 2022 ; 24( 1): 13-27.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s40272-021-00484-wVancouver
Islabao AG, Trindade VC, Mota LMH da, Andrade DCO, Silva CAA da. Managing antiphospholipid syndrome in children and adolescents: current and future prospects [Internet]. Pediatric drugs. 2022 ; 24( 1): 13-27.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s40272-021-00484-w
